Your session is about to expire
β Back to Search
Contrast-Enhanced Mammography for Breast Cancer
Study Summary
This trial is testing whether a new imaging technology, contrast-enhanced mammography, can help predict breast cancer. The technology makes tissue and blood vessels more visible in scans, which may help doctors find suspicious areas of the breast to biopsy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 25 and 85 years old.You have had a bad allergic reaction to iodine dye in the past.I am a woman advised to have a stereotactic biopsy for suspicious breast changes, planning to undergo it at MDACC.My kidneys do not work well.You had a breast biopsy in the same area within the last 2 months.I have not had breast surgery in the last 6 months.
- Group 1: Diagnostic (iodine-based contrast, CEM)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum amount of participants allowable in this trial?
"Affirmative, clinicaltrials.gov indicates that enrollment for this study is ongoing. It was initially posted on April 8th 2021 and the most recent amendment to its description occured on May 1st 2021. This trial requires 100 patients at a single site."
Can elderly individuals aged 65 and older be included in this medical experiment?
"As stipulated in the enrolment criteria for this trial, only individuals aged 25 and over, but no more than 85, are eligible to partake."
Are there any current opportunities to enroll in this trial?
"Affirmative. The data hosted on clinicaltrials.gov reveals the ongoing nature of this medical study, which was first posted on April 8th 2021. 100 participants are needed from a single research centre."
Who is eligible to join this medical experiment?
"This clinical evaluation is seeking 100 women between the ages of 25 and 85 who have been recommended for stereotactic biopsy due to suspicious MADs. Eligible candidates must be willing to partake in this study, receive an IV placement, endure iodinated contrast injection, and provide informed consent. In addition, they must either have had their diagnostic imaging done at MD Anderson Cancer Center or another facility that meets technical mammography criteria."
Share this study with friends
Copy Link
Messenger